Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Rilpivirine MeSH Descriptor Data 2025


MeSH Heading
Rilpivirine
Tree Number(s)
D02.626.809
D03.383.742.755
Unique ID
D000068696
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068696
Scope Note
A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.
Entry Term(s)
R278474
Rilpivirine HCl
Rilpivirine Hydrochloride
TMC 278
TMC-278
TMC278
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
FI96A8X663
0
212WAX8KDD
Related Numbers
212WAX8KDD
500287-72-9
Public MeSH Note
2016; RILPIVIRINE was indexed under NITRILES 2005-2015, and under PYRIMIDINES 2005-2015
History Note
2016 (2005)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/31
Rilpivirine Preferred
R278474 Narrower
TMC 278 Narrower
Rilpivirine Hydrochloride Narrower
page delivered in 0.154s